Jefferies Positive On SXC Health Solutions (SXCK) Takeover, Lifts Price Target

Jefferies boosted its price target on Buy-rated SXC Health Solutions (NASDAQ: SXCI) from $80 to $110 after the deal to acquire Catalyst Health Solutions, saying the acquisition will help it play more aggressive offense.

The firm comments, "We view SXC's pending acquisition of CHSI as a game-changing move that will enable the company to more aggressively play offense to take advantage of emerging market share gain/new contracting opportunities. Given our very robust growth expectations for SXC and our belief that the company will continue to solidify its position as a top player in the PBM space, we remain bullish on the name and reiterate our Buy/PT to $110."

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $89.36 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)